These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37010047)

  • 21. Long-term outcomes of occipital nerve stimulation for chronic migraine: a cohort of 53 patients.
    Miller S; Watkins L; Matharu M
    J Headache Pain; 2016 Dec; 17(1):68. PubMed ID: 27475100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occipital Nerve Stimulation for Refractory Chronic Migraine: Results of a Long-Term Prospective Study.
    Rodrigo D; Acin P; Bermejo P
    Pain Physician; 2017; 20(1):E151-E159. PubMed ID: 28072807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): a randomized, monocentric clinical trial.
    Straube A; Ellrich J; Eren O; Blum B; Ruscheweyh R
    J Headache Pain; 2015; 16():543. PubMed ID: 26156114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of external trigeminal nerve stimulator (e-TNS) on prevention and acute treatment of episodic and chronic migraine: A systematic review.
    Stanak M; Wolf S; Jagoš H; Zebenholzer K
    J Neurol Sci; 2020 May; 412():116725. PubMed ID: 32087428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-invasive vagus nerve stimulation for the management of refractory primary chronic headaches: A real-world experience.
    Trimboli M; Al-Kaisy A; Andreou AP; Murphy M; Lambru G
    Cephalalgia; 2018 Jun; 38(7):1276-1285. PubMed ID: 28899205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial.
    Schoenen J; Vandersmissen B; Jeangette S; Herroelen L; Vandenheede M; Gérard P; Magis D
    Neurology; 2013 Feb; 80(8):697-704. PubMed ID: 23390177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naratriptan in the preventive treatment of refractory chronic migraine: a review of 27 cases.
    Rapoport AM; Bigal ME; Volcy M; Sheftell FD; Feleppa M; Tepper SJ
    Headache; 2003 May; 43(5):482-9. PubMed ID: 12752754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview on effectiveness of erenumab, fremanezumab, and galcanezumab in reducing medication overuse headache in chronic migraine patients.
    Curone M; Tullo V; Didier HA; Bussone G
    Neurol Sci; 2022 Sep; 43(9):5759-5761. PubMed ID: 35836032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. External trigeminal nerve stimulation: Potential rescue treatment for acute vestibular migraine.
    Beh SC
    J Neurol Sci; 2020 Jan; 408():116550. PubMed ID: 31677559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-World Patient Experience With Erenumab for the Preventive Treatment of Migraine.
    Robblee J; Devick KL; Mendez N; Potter J; Slonaker J; Starling AJ
    Headache; 2020 Oct; 60(9):2014-2025. PubMed ID: 32920850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Randomized Controlled Trial of High Rate rTMS Versus rTMS and Amitriptyline in Chronic Migraine.
    Kalita J; Kumar S; Singh VK; Misra UK
    Pain Physician; 2021 Sep; 24(6):E733-E741. PubMed ID: 34554691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mindfulness and pharmacological prophylaxis after withdrawal from medication overuse in patients with Chronic Migraine: an effectiveness trial with a one-year follow-up.
    Grazzi L; Sansone E; Raggi A; D'Amico D; De Giorgio A; Leonardi M; De Torres L; Salgado-García F; Andrasik F
    J Headache Pain; 2017 Dec; 18(1):15. PubMed ID: 28161874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of fremanezumab for migraine prophylaxis in patients with at least three previous preventive failures: Prospective, multicenter, real-world data from a Greek registry.
    Argyriou AA; Dermitzakis EV; Xiromerisiou G; Rallis D; Soldatos P; Litsardopoulos P; Vikelis M
    Eur J Neurol; 2023 May; 30(5):1435-1442. PubMed ID: 36773011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuromodulation for Chronic Daily Headache.
    Coppola G; Magis D; Casillo F; Sebastianelli G; Abagnale C; Cioffi E; Di Lenola D; Di Lorenzo C; Serrao M
    Curr Pain Headache Rep; 2022 Mar; 26(3):267-278. PubMed ID: 35129825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral Neuromodulation for the Management of Headache.
    Urits I; Schwartz R; Smoots D; Koop L; Veeravelli S; Orhurhu V; Cornett EM; Manchikanti L; Kaye AD; Imani F; Varrassi G; Viswanath O
    Anesth Pain Med; 2020 Dec; 10(6):e110515. PubMed ID: 34150578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Remote electrical neuromodulation for acute treatment of migraine in adolescents.
    Hershey AD; Lin T; Gruper Y; Harris D; Ironi A; Berk T; Szperka CL; Berenson F
    Headache; 2021 Feb; 61(2):310-317. PubMed ID: 33349920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective cohort study of routine exercise and headache outcomes among adults with episodic migraine.
    Hagan KK; Li W; Mostofsky E; Bertisch SM; Vgontzas A; Buettner C; Mittleman MA
    Headache; 2021 Mar; 61(3):493-499. PubMed ID: 33349935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Onabotulinumtoxin-A treatment in Greek patients with chronic migraine.
    Vikelis M; Argyriou AA; Dermitzakis EV; Spingos KC; Mitsikostas DD
    J Headache Pain; 2016 Dec; 17(1):84. PubMed ID: 27640152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program.
    Aurora SK; Dodick DW; Diener HC; DeGryse RE; Turkel CC; Lipton RB; Silberstein SD
    Acta Neurol Scand; 2014 Jan; 129(1):61-70. PubMed ID: 24107267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headache.
    Marmura MJ; Diener HC; Cowan RP; Tepper SJ; Diamond ML; Starling AJ; Hirman J; Mehta L; Brevig T; Cady R
    Headache; 2021 Oct; 61(9):1421-1431. PubMed ID: 34551130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.